Yuhan Corp. Total Liabilities
Yuhan Corp. total liabilities. Based on the latest financial reports, Yuhan Corp. (000100) has total liabilities worth ₩858.64 Billion KRW (≈ $581.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000100 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Yuhan Corp. (2000–2025)
Total liabilities of Yuhan Corp. from 2000 to 2025. This chart illustrates how Yuhan Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore Yuhan Corp. long-term investment intensity to see how much of total assets are deployed in long-term investments.
Yuhan Corp. Competitors by Total Liabilities
The table below lists competitors of Yuhan Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kinaxis Inc
TO:KXS
|
Canada | CA$302.77 Million |
|
Alm. Brand
CO:ALMB
|
Denmark | Dkr20.05 Billion |
|
Imeik Technology Development Co
SHE:300896
|
China | CN¥679.01 Million |
|
BancFirst Corporation
NASDAQ:BANF
|
USA | $8.67 Billion |
|
T&S Communications Co Ltd
SHE:300570
|
China | CN¥426.72 Million |
|
NEXI SPA (UNSP.ADR)/1
F:N0X0
|
Germany | €13.15 Billion |
|
Planet Fitness Inc
NYSE:PLNT
|
USA | $3.62 Billion |
|
Shapir Engineering Industry
TA:SPEN
|
Israel | ILA12.93 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Yuhan Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Yuhan Corp..
Liquidity & Leverage Metrics
Yuhan Corp. Total Liabilities Ratios Explained
Yuhan Corp. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yuhan Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yuhan Corp. (2000–2025)
The table below shows the annual total liabilities of Yuhan Corp. from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩858.64 Billion ≈ $581.89 Million |
+8.50% |
| 2024-12-31 | ₩791.38 Billion ≈ $536.31 Million |
+11.20% |
| 2023-12-31 | ₩711.65 Billion ≈ $482.27 Million |
+53.07% |
| 2022-12-31 | ₩464.92 Billion ≈ $315.07 Million |
-11.93% |
| 2021-12-31 | ₩527.92 Billion ≈ $357.77 Million |
-3.49% |
| 2020-12-31 | ₩547.02 Billion ≈ $370.71 Million |
+17.08% |
| 2019-12-31 | ₩467.21 Billion ≈ $316.62 Million |
-10.51% |
| 2018-12-31 | ₩522.08 Billion ≈ $353.80 Million |
+6.91% |
| 2017-12-31 | ₩488.35 Billion ≈ $330.95 Million |
-11.11% |
| 2016-12-31 | ₩549.39 Billion ≈ $372.31 Million |
+6.39% |
| 2015-12-31 | ₩516.39 Billion ≈ $349.95 Million |
+51.83% |
| 2014-12-31 | ₩340.11 Billion ≈ $230.49 Million |
+19.03% |
| 2013-12-31 | ₩285.72 Billion ≈ $193.63 Million |
+32.98% |
| 2012-12-31 | ₩214.87 Billion ≈ $145.61 Million |
+8.88% |
| 2011-12-31 | ₩197.34 Billion ≈ $133.74 Million |
+7.96% |
| 2010-12-31 | ₩182.79 Billion ≈ $123.87 Million |
+9.40% |
| 2009-12-31 | ₩167.09 Billion ≈ $113.23 Million |
-5.22% |
| 2008-12-31 | ₩176.29 Billion ≈ $119.47 Million |
-26.77% |
| 2007-12-31 | ₩240.74 Billion ≈ $163.15 Million |
-10.50% |
| 2006-12-31 | ₩268.99 Billion ≈ $182.29 Million |
-12.04% |
| 2005-12-31 | ₩305.81 Billion ≈ $207.24 Million |
+24.37% |
| 2004-12-31 | ₩245.88 Billion ≈ $166.63 Million |
+24.47% |
| 2003-12-31 | ₩197.55 Billion ≈ $133.87 Million |
-11.46% |
| 2002-12-31 | ₩223.10 Billion ≈ $151.19 Million |
+4.10% |
| 2001-12-31 | ₩214.31 Billion ≈ $145.24 Million |
-7.84% |
| 2000-12-31 | ₩232.55 Billion ≈ $157.60 Million |
-- |
About Yuhan Corp.
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more